Epidemiology

Joint report with the WHO Regional Office for Europe on HIV/AIDS surveillance – 2021 data

shabnam.abdullayeva_2293 — Fri, 23 Dec 2022 11:32:17 +0000

Joint report with the WHO Regional Office for Europe on HIV/AIDS surveillance – 2021 data shabnam.abdullayeva_2293 Fri, 12/23/2022 - 11:32

HIV transmission remains a major public health concern and affects more than 2.3 million people in the WHO European Region, particularly in the Eastern part of the Region. This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007. It finds that while epidemic patterns and trends vary widely across European countries, nearly 107 000 people were diagnosed with HIV in the European Region in 2022, including around 17 000 in the EU/EEA.

Report ECDC, WHO

Is the material copyright protected?

Yes

Website

https://www.ecdc.europa.eu/en/publications-data/hiv-aids-joint-report-surveillance-2021-data

(Undocumented) Migrants

Gay men and other MSM

Heterosexuals

Injecting drug users (IDUs)

LGBTI

Men having sex with men (MSM)

People living with HIV (PLHIV)

Sex workers

Women

WHO European region

Co-infections

Epidemiology

Gender

Prevention

Sexual and reproductive health

Increase in severe acute hepatitis cases of unknown aetiology in children

shabnam.abdullayeva_2293 — Wed, 27 Jul 2022 12:40:47 +0000

Increase in severe acute hepatitis cases of unknown aetiology in children shabnam.abdullayeva_2293 Wed, 07/27/2022 - 12:40

As of 20 April 2022, 111 cases had been reported from the UK, and as of 27 April 2022 approximately 55 probable and confirmed cases have been reported from 12 EU/EEA countries. An additional 12 cases have been reported from the United States (US), 12 from Israel, and one from Japan. The clinical picture is of severe acute hepatitis requiring hospitalisation with jaundice and markedly elevated liver transaminases. In most cases to date, the onset of jaundice was preceded by a gastrointestinal illness with vomiting, diarrhoea, and nausea. Information on the outcome of the cases is still being collected. So far, most patients for whom information is available have recovered, but a number have progressed to acute liver failure and required liver transplantation.

Report

Year

2022 ECDC

Is the material copyright protected?

I don't know

Website

https://www.ecdc.europa.eu/en/publications-data/increase-severe-acute-hepatitis-cases-unknown-aetiology-children

RRA-20220420-218-erratum.pdf

General public

Youth

WHO European region

Co-infections

Epidemiology

Viral hepatitis

Joint WHO Regional Office for Europe/ECDC Monkeypox Resource toolkit to support national authorities and event organisers in their planning and coordination of mass and large gathering events

shabnam.abdullayeva_2293 — Thu, 07 Jul 2022 12:00:54 +0000

Joint WHO Regional Office for Europe/ECDC Monkeypox Resource toolkit to support national authorities and event organisers in their planning and coordination of mass and large gathering events shabnam.abdullayeva_2293 Thu, 07/07/2022 - 12:00

This toolkit, jointly created by the World Health Organization (WHO) Regional Office for Europe and the European Centre for Disease Prevention and Control (ECDC), provides health authorities and event organisers with ready-to-use and customisable tools for public health preparedness and risk assessment; early warning, alert and response (EWAR); and event-based surveillance; contact tracing; and risk communication and community engagement (RCCE) including health information and advice on monkeypox for mass gatherings.

This resource toolkit accompanies the Interim advice for public health authorities on summer events during the monkeypox outbreak in Europe, 2022, aiming to provide concise advice to public health authorities and guide their prevention and RCCE interventions before, during, and after upcoming summer events. The toolkit offers a one-stop-shop for technical guidance, trainings, materials and operational tools to support health authorities and event organisers prepare for upcoming large and mass gathering events during the summer. The toolkit will be updated with new materials and resources over time. Different sections can be used by health authorities and other audiences to formulate advice to business and venue owners and event organisers, as well as participants themselves. All advice can be adapted to the local context and the relevant audience and translated into national languages as required.

Other

Year

2022 WHO, ECDC

Is the material copyright protected?

Yes

Website

https://www.who.int/europe/publications/m/item/joint-who-regional-office-for-europe-ecdc-monkeypox-resource-toolkit-to-support-national-authorities-and-event-organisers-in-their-planning-and-coordination-of-mass-and-large-gathering-events

General public

NGOs

WHO European region

Epidemiology

Molecular HIV Surveillance: A Global Review of Human Rights Implications

admin — Mon, 13 Dec 2021 13:01:00 +0000

Molecular HIV Surveillance: A Global Review of Human Rights Implications admin Mon, 12/13/2021 - 13:01

“Molecular HIV Surveillance: A global review of human rights implications” provides a detailed explanation of what MHS is and how it is used across the globe, including how the technology works, where it is being conducted, and by whom. The paper describes growing human rights concerns relating to the use of this technology and goes on to list a number of recommendations for the use of MHS which were gathered from an international literature review and from members of the Expert Advisory Group.

Molecular HIV surveillance (MHS) is an umbrella term that describes a wide range of practices focused on the monitoring of HIV variants and the differences and similarities between them for scientific research, public health surveillance and intervention.

The paper is available in English, Russian, Spanish, French.

Year

2021 HIV Justice Worldwide, Positive Women's Network

Is the material copyright protected?

I don't know

Website

https://www.hivjusticeworldwide.org/en/mhs/

MHS-Paper-French.pdf

General public

People living with HIV (PLHIV)

Global

Epidemiology

Laws and regulations

Legislation

Policy

Research

Drug-related infectious diseases: health and social responses

shabnam.abdullayeva_2293 — Sat, 11 Dec 2021 23:06:00 +0000

Drug-related infectious diseases: health and social responses shabnam.abdullayeva_2293 Sat, 12/11/2021 - 23:06

This miniguide on responding to drug-related infectious diseases is one of a larger set, which together comprise Health and social responses to drug problems: a European guide 2021. It provides an overview of the most important aspects to consider when planning or delivering health and social responses to drug-related infectious diseases, and reviews the availability and effectiveness of the responses. It also considers implications for policy and practice.

Report European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

Is the material copyright protected?

I don't know

Website

https://www.emcdda.europa.eu/publications/mini-guides/drug-related-infectious-diseases-health-and-social-responses_en#section2

www.emcdda.europa.eu%20-%20Drug-related%20infectious%20diseases%20health%20and%20social%20responses%20-%202021-12-17.pdf

General public

Injecting drug users (IDUs)

Central Europe

Southern Europe

Western Europe

Co-infections

Epidemiology

Harm reduction

Testing and counselling

Tubercolosis

Viral hepatitis

HIV/AIDS surveillance in Europe 2021 (2020 data)

admin — Thu, 02 Dec 2021 22:14:00 +0000

HIV/AIDS surveillance in Europe 2021 (2020 data) admin Thu, 12/02/2021 - 22:14

This report has been published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe.

To better understand the extent to which the pandemic affected 2020 HIV/AIDS surveillance data, the World Health Organization Regional Office for Europe and the European Centre for Disease Prevention and Control conducted a short survey that was sent to all 55 countries, territories and areas of the WHO European Region; 21 responses were received. The survey focused on the issues of reduced detection and reporting of HIV cases and on the issue of completeness of some enhanced variables.

Year

2022 European Centre for Disease Prevention and Control (ECDC), WHO Regional Office for Europe.

Is the material copyright protected?

I don't know

Website

https://www.ecdc.europa.eu/en/publications-data/hiv-aids-surveillance-europe-2021-2020-data

Gay men and other MSM

General public

Injecting drug users (IDUs)

LGBTI

Migrants

People living with HIV (PLHIV)

People who use drugs (PUD)

Sex workers

Women

WHO European region

Co-infections

Epidemiology

Gender

Harm reduction

Sexual and reproductive health

Testing and counselling

Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus

admin — Sun, 28 Nov 2021 11:41:00 +0000

Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus admin Sun, 11/28/2021 - 11:41

This document, the third version, adds on EMTCT of hepatitis B virus (HBV), bringing together a package of interventions and metrics to support integrated management and monitoring of vertical transmission across a wide range of epidemiological and programmatic contexts.

Establishment of criteria for validation began in 2007 with global consultations while lessons learnt advised publication of 2 editions of global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis

Report

Year

2021 WHO

Is the material copyright protected?

I don't know

Website

https://www.who.int/publications/i/item/9789240039360

General public

Heterosexuals

People living with HIV (PLHIV)

Women

Global

Care and support

Co-infections

Epidemiology

Prevention

Reproductive health

Перспективные препараты против ВИЧ в 2021 году: Новые препараты в разработке

admin — Fri, 15 Oct 2021 13:52:00 +0000

Перспективные препараты против ВИЧ в 2021 году: Новые препараты в разработке admin Fri, 10/15/2021 - 13:52

В данном отчете рассматриваются достижения в разработке против ВИЧ в 2021 году.

Многие из разрабатываемых соединений потенциально могут быть использованы как для лечения, так и для профилактики. Кроме того, впервые за многие годы большая часть текущих разработок относится к новым классам препаратов, которые могут быть использованы для людей, не получающих лечения, не имеющих опыта лечения и пациентов, живущих с ВИЧ с множественной лекарственной устойчивостью.

Year

2021 HIV i-BASE

Is the material copyright protected?

I don't know

Website

https://i-base.info/htb/wp-content/uploads/2021/09/PIPELINE-Aug-2021-FINAL-corrected-ru.pdf

PIPELINE-Aug-2021-FINAL-corrected-ru.pdf

Health care professionals

People living with HIV (PLHIV)

Global

Epidemiology

Prevention

Research

Treatment

HIV Continuum of care: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2020 progress report)

admin — Thu, 19 Aug 2021 16:51:00 +0000

HIV Continuum of care: Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia (2020 progress report) admin Thu, 08/19/2021 - 16:51

This progress report of the European Centre for Disease Prevention and Control (ECDC) is one in a series of thematic reports based on information submitted by reporting countries in 2020 on monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS.

In 2020, 40 out of 55 countries in Europe and Central Asia provided the latest available data on all four stages of the continuum of HIV care (compared to 34 countries in 2018). A total of 45 countries were able to provide data for at least two consecutive stages of the continuum of HIV care (compared to 42 in 2018).

Report

Year

2021 The European Centre for Disease Prevention and Control (ECDC)

Is the material copyright protected?

I don't know

Website

https://www.ecdc.europa.eu/en/publications-data/hiv-continuum-care-monitoring-implementation-dublin-declaration

hiv-continuum-of-care-dublin-declaration-2021.pdf

(Undocumented) Migrants

Gay men and other MSM

General public

Injecting drug users (IDUs)

LGBTI

Men having sex with men (MSM)

Migrants

People living with HIV (PLHIV)

People who are/were in prisons

People who use drugs (PUD)

Prisoners (ex-)

Refugees

Sex workers

Women

Youth

WHO European region

Advocacy

Care and support

Epidemiology

Harm reduction

Inequalities in health

Pre-exposure prophylaxis (PrEP)

Reproductive health

Research

Sexual and reproductive health

STI's

Treatment

Treatment as prevention (TasP)

Tubercolosis

Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring

admin — Thu, 25 Mar 2021 14:06:00 +0000

Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring admin Thu, 03/25/2021 - 14:06

These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living with HIV who are being treated for tuberculosis.

WHO

Is the material copyright protected?

I don't know

Website

https://www.who.int/publications/i/item/9789240022232

General public

People living with HIV (PLHIV)

Youth

Global

Co-infections

Epidemiology

Testing and counselling

Treatment